https://transhumanist.ru/index.php?action=history&feed=atom&title=PTPN22PTPN22 - История изменений2026-06-05T21:37:31ZИстория изменений этой страницы в викиMediaWiki 1.43.6https://transhumanist.ru/index.php?title=PTPN22&diff=5359&oldid=prevOdysseusBot: Новая страница: «Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domai...»2021-05-12T13:40:36Z<p>Новая страница: «Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domai...»</p>
<p><b>Новая страница</b></p><div>Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP) [PTPN8]<br />
<br />
==Publications==<br />
<br />
{{medline-entry<br />
|title=[[PTPN22]] 1858C>T (R620W) functional polymorphism and human longevity.<br />
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/21113673<br />
|abstract=The [[PTPN22]] gene, located on chromosome 1p13, encoding lymphoid protein tyrosine phosphatase (LYP), plays a crucial role in the negative control of T lymphocyte activation. Since the age-related change in T-cell signal transduction may be one of the most important causes of cell-mediated immune response decline with ageing, we performed a population-based association study to test whether the [[PTPN22]] 1858C>T (R620W) functional polymorphism affects the ability to survive to old age and to reach even exceptional life expectancy. 892 unrelated healthy individuals (age range 8-106 years, 403 males and 489 females) from central Italy were studied. For both gender, the frequency of [[PTPN22]]*T1858 carriers does not differ significantly in nona/centenarians and in octogenarians respect to young group. Allele and genotype frequencies of age groups were compared to those reported in previously published studied carried out on control individuals with Italic ancestry (N = 1393), further confirming results obtained from our sample population. Overall, our study suggests that [[PTPN22]]*T1858 allele is not negatively selected at oldest ages and we speculate that its increased ability to protect individuals against development of infectious diseases may counteract its deleterious effect on immune system leading to autoimmunity.<br />
|mesh-terms=* Adolescent<br />
* Adult<br />
* Aged<br />
* Aged, 80 and over<br />
* Child<br />
* Female<br />
* Gene Frequency<br />
* Genotype<br />
* Humans<br />
* Italy<br />
* Longevity<br />
* Male<br />
* Middle Aged<br />
* Models, Genetic<br />
* Polymorphism, Single Nucleotide<br />
* Protein Tyrosine Phosphatase, Non-Receptor Type 22<br />
* Young Adult<br />
<br />
|full-text-url=https://sci-hub.do/10.1007/s11033-010-0546-8<br />
}}</div>OdysseusBot